4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-23-001675
Chief Executive Officer gave 127,850 shares (gift)
- Chief Executive Officer gave 127,850 shares (gift)
- Chief Executive Officer disposed of 189,310 shares (other)
- Chief Executive Officer acquired 189,310 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-02-10 | Gift | −123,479 | 23,000 | D | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-02-10 | Gift | +123,479 | 448,704 | I | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-10-25 | Other acquisition | +4,371 | 67,371 | D | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-10-25 | Other disposition | −4,371 | 444,333 | I | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2023-02-17 | Gift | −4,371 | 63,000 | D | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2023-02-17 | Gift | +4,371 | 448,704 | I | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2023-02-17 | Other disposition | −184,939 | 448,704 | I | ||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2023-02-17 | Other acquisition | +184,939 | 448,704 | I |
Loading xslF345X03/primarydocument.xml…